Expertise in
11
conditions

Motohiro Tamiya

Osaka, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
11
conditions
Osaka, JP 

Overview

Motohiro Tamiya practices practicing medicine in Osaka, Japan.

Tamiya is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleural Effusion, EGFR Positive Lung Cancer, and Endoscopy.

They are actively involved in clinical research, co-authoring 193 peer reviewed articles and participating in 1 clinical trial.

Locations

Osaka, Japan
Other Locations
Chuo, 5418567, Japan
Habikino, Japan
Otemae, 5418567, Japan
Nakamichi, 5378511, Japan
Sakai, 5918555, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2

193 Total Publications

Comparative effectiveness of immunotherapeutic regimens for untreated advanced non-small-cell lung cancer in real-world clinical practice: a Japanese cancer registry cohort study.
Comparative effectiveness of immunotherapeutic regimens for untreated advanced non-small-cell lung cancer in real-world clinical practice: a Japanese cancer registry cohort study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Frequently Asked Questions about Motohiro Tamiya

Is Motohiro Tamiya a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Motohiro Tamiya is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Motohiro Tamiya participate in research or clinical trials?

Yes. Motohiro Tamiya has published 193 articles and abstracts on conditions like Lung Cancer. You can view a list of Motohiro Tamiya's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tamiya's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile